Schedule 13G ownership disclosure

MILESTONE PHARMACEUTICALS IN

Security class unavailable · CUSIP: 59935V107

Event date: 2020-03-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-043073
Form type
SC 13G/A
Filer
Milestone Pharmaceuticals Inc.
CIK
CIK 1408443
Filed
Apr 03, 2020
Reporting period
Mar 25, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub